Sigma Square Capital

ABclonal Inc. is a life science research and diagnostic reagents provider based in Woburn, Massachusetts, founded in 2016. The company specializes in offering a variety of biological research agents and services, including next generation sequencing library preparation kits, molecular biology products, catalog antibodies, catalog proteins, ELISA kits, and western blot tools and reagents. In addition to its extensive product range, ABclonal provides customized services related to peptides, antibodies, and proteins. The company distributes its products through a network of distributors across Europe, Asia, North America, and Oceania, aiming to enhance the quality of life science research with its high-quality offerings.

Waytous is a technology company based in Qingdao, China, specializing in autonomous driving solutions for the mining and construction sectors. Established in November 2014, Waytous develops a cloud-based intelligent driving technology that facilitates unmanned operation of mining trucks and collaborative management of excavators. The company emphasizes the creation of training data and a research and development ecosystem tailored to intelligent vehicle applications, enabling clients to enhance the performance and reliability of their autonomous systems.

Developer of cloud based intelligent autonomous driving technology. The company focuses on building the training data and R&D ecosystem around the intelligent vehicles field, empowering its clients to improve the quality of their autonomous car systems. The company's mission is to build the world leading cloud based intelligent autonomous driving ecosystem.

Developer of cloud based intelligent autonomous driving technology. The company focuses on building the training data and R&D ecosystem around the intelligent vehicles field, empowering its clients to improve the quality of their autonomous car systems. The company's mission is to build the world leading cloud based intelligent autonomous driving ecosystem.

Beijing GenomePrecision Technology Co., Ltd. is a molecular diagnostic company focused on developing precision medicine tests to enhance the diagnosis and treatment of various diseases, including blood tumors, transplantation needs, and cardiovascular conditions. Established in 2015 and headquartered in Beijing, the company integrates research and development, manufacturing, distribution, and registration of its products. GenomePrecision utilizes advanced molecular technology platforms, such as real-time fluorescence quantitative PCR, Sanger sequencing, high-throughput next-generation sequencing, and capillary electrophoresis, to create a diverse range of diagnostic products. These include tests for leukemia, lymphoma, solid tumors, and pharmacogenomics, as well as tools for organ transplant monitoring and pathogen detection. The company also produces molecular diagnostic kits for targeted drug testing and auxiliary diagnosis of cervical cancer, among other applications. By focusing on clinical diagnosis and treatment requirements, GenomePrecision aims to improve patient outcomes through innovative molecular diagnostics.

Iris Integrated Retail Information Solution is a provider of enterprise services focused on information technology for the retail sector. Based in Shanghai, China, the company offers a range of solutions, including IT retail data operations, business intelligence IT solutions, and cloud-based management systems. Iris specializes in the Iris BI 1.2 Pro series, an integrated application designed for various businesses involved in retail data processing. Additionally, the company develops mobile applications and offers services such as mobile IT product solutions, eBook production, and app development. Iris also provides IT consulting and training services, catering to the diverse needs of its clients in the retail industry.

Shenzhen Fanlai Technology Co., Ltd. specializes in the development of smart kitchen appliances, focusing on household technology that enhances cooking experiences. The company offers innovative kitchen automation solutions that integrate intelligent functionalities with artificial intelligence, allowing consumers to prepare homemade meals with greater convenience and efficiency. Headquartered in Shenzhen, China, Fanlai Tech aims to streamline cooking processes and elevate the overall kitchen experience for consumers.

Liking Fit is a Chinese franchise smart gym operator, established in September 2014 and headquartered in Shanghai. The company specializes in the development and operation of 24-hour intelligent gyms, utilizing an online platform that allows users to access facilities via a mobile app or smartwatches. This innovative approach enables members to engage in fitness activities at their convenience while also monitoring their health data on the cloud. Liking Fit supports its franchisees by providing a comprehensive range of services, including gym outfitting, smart technical assistance, training, promotion, and post-management. The franchise model allows for a unique unmanned management system, where franchisees can oversee operations through mobile devices. Currently, Liking Fit has formed strategic partnerships with notable real estate companies and has established over 100 franchise locations worldwide.

No Panda Culture (Bukongwenhua) is a Shanghai-based entertainment and culture agency.

Withwheat is a Beijing-based bakery chain renowned for its European-style soft bread. It distinguishes itself by using minimal sugar (10% of regular bread) and oil (6%), with no preservatives, trans fats, or added flavors. This commitment to quality has made Withwheat's products highly sought after among consumers in the region.

DeePhi Technology Co., Ltd., founded in 2016 and based in Beijing, China, specializes in developing deep learning artificial intelligence (AI) computing applications. The company focuses on creating automation flows for compression, compiling, and acceleration, achieving joint optimization between algorithms, software, and hardware. DeePhi Tech offers solutions for various terminals, from large servers to small mobile devices, utilizing a new processing unit called DPU for low-power, high-performance intelligent processing. Their technology is applied in neural network compression, compilation, processor design, and FPGA programming, serving industries such as drones, security surveillance, and cloud services. DeePhi Technology aims to provide efficient, convenient, and economical inference platforms for both embedded and server-side applications.

Manman is a mobile comics platform established in Beijing in 2017, specializing in the production and distribution of original comic content. With over 980 titles available, including 315 exclusives, the app has cultivated a user base exceeding 14 million, of which 3 million are active users. Notably, 2 million users maintain more than 20 subscriptions, demonstrating a strong engagement with the platform. Manman aims to generate revenue through paid subscriptions, advertising, and reward systems, enhancing the entertainment experience for its audience by providing diverse and novel comic topics.

Beijing GenomePrecision Technology Co., Ltd. is a molecular diagnostic company focused on developing precision medicine tests to enhance the diagnosis and treatment of various diseases, including blood tumors, transplantation needs, and cardiovascular conditions. Established in 2015 and headquartered in Beijing, the company integrates research and development, manufacturing, distribution, and registration of its products. GenomePrecision utilizes advanced molecular technology platforms, such as real-time fluorescence quantitative PCR, Sanger sequencing, high-throughput next-generation sequencing, and capillary electrophoresis, to create a diverse range of diagnostic products. These include tests for leukemia, lymphoma, solid tumors, and pharmacogenomics, as well as tools for organ transplant monitoring and pathogen detection. The company also produces molecular diagnostic kits for targeted drug testing and auxiliary diagnosis of cervical cancer, among other applications. By focusing on clinical diagnosis and treatment requirements, GenomePrecision aims to improve patient outcomes through innovative molecular diagnostics.

Novogene Co., Ltd. is a prominent global provider of genomic services and solutions, specializing in next-generation sequencing (NGS) and bioinformatics. Founded in 2011 and headquartered in Beijing, China, the company operates with a large workforce and boasts the highest sequencing capacity worldwide. Novogene offers a wide range of genomic solutions, including human genome sequencing, cancer genomic profiling, and various applications for animals, plants, and microbes. Their advanced services also encompass clinical-grade whole exome sequencing and specialized diagnostic assays for cancer therapies. The company is recognized for its commitment to data quality and customer service, having produced over 1850 research papers in prestigious journals. Dr. Ruiqiang Li, the founder and a leading expert in genomics, has significantly contributed to the field through multiple patents and influential publications, fostering Novogene's reputation as a leader in the genomics sector.